Insulin Glargine (U-100) Cartridge Systems and Pens and Pertuzumab Intravenous
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Pertuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: pertuzumab
Brand name: Perjeta
Synonyms: Pertuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pertzye
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pexeva
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pexidartinib
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pexidartinib Hydrochloride
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pfizerpen
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pharaon Tea
- Pertuzumab Intravenous-Insulin Glargine (U-100) Vials
- Pertuzumab Intravenous-Insulin Glargine (U-300) Pens
- Pertuzumab Intravenous-Insulin glargine and lixisenatide
- Pertuzumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Pertuzumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Pertuzumab Intravenous-Insulin glulisine